NASDAQ: AEMD
Aethlon Medical Inc Stock

$0.39+0.01 (+2.63%)
Updated Dec 6, 2024
AEMD Price
$0.39
Fair Value Price
N/A
Market Cap
$5.46M
52 Week Low
$0.24
52 Week High
$2.35
P/E
-0.14x
P/B
0.91x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$11.27M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.47
Operating Cash Flow
-$9M
Beta
0.54
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

AEMD Overview

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine AEMD's potential to beat the market

Zen Rating Component Grades

N/A
Value
N/A
Growth
N/A
Momentum
N/A
Sentiment
N/A
Safety
N/A
Financials
N/A
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Device

Industry Rating
D
AEMD
Ranked
Unranked of 127

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$28.71A
$11.68A
$49.71A
View Top Medical Device Stocks

Be the first to know about important AEMD news, forecast changes, insider trades & much more!

AEMD News

Overview

Due Diligence Score

Industry Average (26)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how AEMD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

AEMD is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AEMD is good value based on its book value relative to its share price (0.91x), compared to the US Medical Devices industry average (4.05x)
P/B vs Industry Valuation
AEMD is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more AEMD due diligence checks available for Premium users.

Valuation

AEMD price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-0.14x
Industry
36.83x
Market
29.86x

AEMD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.91x
Industry
4.05x
AEMD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

AEMD's financial health

Profit margin

Revenue
$0.0
Net Income
-$2.8M
Profit Margin
0%
AEMD's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$8.8M
Liabilities
$2.8M
Debt to equity
0.47
AEMD's short-term assets ($7.14M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AEMD's short-term assets ($7.14M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AEMD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AEMD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.2M
Investing
$0.0
Financing
-$3.8k
AEMD's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

AEMD vs Medical Device Stocks

TickerZen RatingMarket Cap1d %P/EP/B
AEMD$5.46M+3.99%-0.14x0.91x
NUWEC$5.55M+1.60%-0.02x1.75x
SINTC$5.01M+8.43%-0.03x0.90x
AIMD$5.95M+0.47%-0.15x0.33x
BMRA$4.88M-19.44%-0.78x0.91x

Aethlon Medical Stock FAQ

What is Aethlon Medical's quote symbol?

(NASDAQ: AEMD) Aethlon Medical trades on the NASDAQ under the ticker symbol AEMD. Aethlon Medical stock quotes can also be displayed as NASDAQ: AEMD.

If you're new to stock investing, here's how to buy Aethlon Medical stock.

What is the 52 week high and low for Aethlon Medical (NASDAQ: AEMD)?

(NASDAQ: AEMD) Aethlon Medical's 52-week high was $2.35, and its 52-week low was $0.24. It is currently -83.36% from its 52-week high and 64.98% from its 52-week low.

How much is Aethlon Medical stock worth today?

(NASDAQ: AEMD) Aethlon Medical currently has 13,961,998 outstanding shares. With Aethlon Medical stock trading at $0.39 per share, the total value of Aethlon Medical stock (market capitalization) is $5.46M.

Aethlon Medical stock was originally listed at a price of $1,341.00 in Jul 13, 2015. If you had invested in Aethlon Medical stock at $1,341.00, your return over the last 9 years would have been -99.97%, for an annualized return of -59.52% (not including any dividends or dividend reinvestments).

How much is Aethlon Medical's stock price per share?

(NASDAQ: AEMD) Aethlon Medical stock price per share is $0.39 today (as of Dec 6, 2024).

What is Aethlon Medical's Market Cap?

(NASDAQ: AEMD) Aethlon Medical's market cap is $5.46M, as of Dec 8, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Aethlon Medical's market cap is calculated by multiplying AEMD's current stock price of $0.39 by AEMD's total outstanding shares of 13,961,998.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.